Suchergebnisse - "Strub-Wourgaft, Nathalie"

PubPharm (63)

21

Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic

enthalten in: EClinicalMedicine | 2021

von Hotez, P. | Batista, C. | Amor, Y. | +18

22

Achieving global equity for COVID-19 vaccines : Stronger international partnerships and greater advocacy and solidarity are needed

enthalten in: PLoS medicine | 2021

von Figueroa, J. | Hotez, P. | Batista, C. | +18

23

The Chagas disease study landscape : A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform

enthalten in: PLoS neglected tropical diseases | 2021

von Maguire, B. | Dahal, P. | Rashan, S. | +8

24

New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA) : a phase 2, double-blind, randomised trial

enthalten in: The Lancet. Infectious diseases | 2021

von Torrico, F. | Gascón, J. | Barreira, F. | +34

CommentIn: Lancet Infect Dis. 2021 Aug;21(8):1057-1058. - PMID 33836159

25

Benznidazole in Chagas disease study : do the data justify progression to phase 3? - Authors' reply

enthalten in: The Lancet. Infectious diseases | 2021

von Torrico, F. | Barreira, F. | Strub-Wourgaft, N. | +2

CommentOn: Lancet Infect Dis. 2021 Aug;21(8):1129-1140. - PMID 33836161

26

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis : a prospective, multicentre, open-label, cohort study

enthalten in: The Lancet. Global health | 2021

von Kande Betu Ku Mesu, V. | Mutombo Kalonji, W. | Bardonneau, C. | +21

27

WHO COVID-19 therapeutic guidelines - Authors' reply

enthalten in: Lancet (London, England) | 2021

von White, N. | Strub-Wourgaft, N. | Faiz, A. | +1

CommentOn: Lancet. 2021 Jul 10;398(10295):117-118. - PMID 34246341

28

Operation Warp Speed : implications for global vaccine security

enthalten in: The Lancet. Global health | 2021

von Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members | Kim, J. | Hotez, P. | +16

29

Urgent needs to accelerate the race for COVID-19 therapeutics

enthalten in: EClinicalMedicine | 2021

von Batista, C. | Shoham, S. | Ergonul, O. | +17

30

Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis

enthalten in: bioRxiv.org | 2021

von Guérin, P. | McLean, A. | Rashan, S. | +4